chr8-93780633-T-C
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PM5PP3PP5_Very_Strong
The ENST00000453321.8(TMEM67):āc.755T>Cā(p.Met252Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M252I) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000453321.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM67 | NM_153704.6 | c.755T>C | p.Met252Thr | missense_variant | 8/28 | ENST00000453321.8 | NP_714915.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM67 | ENST00000453321.8 | c.755T>C | p.Met252Thr | missense_variant | 8/28 | 1 | NM_153704.6 | ENSP00000389998 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152244Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251348Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135846
GnomAD4 exome AF: 0.0000985 AC: 144AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.000103 AC XY: 75AN XY: 727208
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74380
ClinVar
Submissions by phenotype
not provided Pathogenic:7
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | TMEM67: PM3:Very Strong, PM1, PM2 - |
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 08, 2023 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 17397051, 19466712, 29568536, 20232449, 21866095, 19508969, 26092869, 28497568, 29146704, 23351400, 31589614, 34426522, 36090483, 36788019) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 07, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
Joubert syndrome 6 Pathogenic:2
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2009 | - - |
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 252 of the TMEM67 protein (p.Met252Thr). This variant is present in population databases (rs202149403, gnomAD 0.01%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 17397051, 28497568, 29568536). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1387). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TMEM67 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects TMEM67 function (PMID: 26035863). For these reasons, this variant has been classified as Pathogenic. - |
Meckel syndrome, type 3;C1853153:Joubert syndrome 6;C1865794:RHYNS syndrome;C2673874:Bardet-Biedl syndrome 14;C3150796:Nephronophthisis 11;C5435651:COACH syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 05, 2022 | - - |
Joubert syndrome and related disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 21, 2024 | Variant summary: TMEM67 c.755T>C (p.Met252Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8.4e-05 in 251348 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TMEM67 causing Joubert Syndrome And Related Disorders (8.4e-05 vs 0.0018), allowing no conclusion about variant significance. c.755T>C has been reported in the literature in compound heterozygous state in multiple individuals affected with Joubert Syndrome And Related Disorders and in at least one family, this variant has been shown to segregate with disease in three siblings (e.g. Otto_2010, Szymanska_2012, Bachmann-Gagescu_2015, Hickey_2018). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 26092869, 29568536, 23351400, 21068128). ClinVar contains an entry for this variant (Variation ID: 1387). Based on the evidence outlined above, the variant was classified as pathogenic. - |
TMEM67-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 05, 2024 | The TMEM67 c.755T>C variant is predicted to result in the amino acid substitution p.Met252Thr. This variant has been reported in the compound heterozygous state in multiple individuals with Meckel syndrome (gene referred to as MSK3 in Khaddour et al. 2007. PubMed ID: 17397051; Chaki et al. 2011. PubMed ID: 21866095; Bachmann-Gagescu et al. 2015. PubMed ID: 26092869). A functional study using mouse embryonic fibroblasts (MEFs) showed that the p.Met252Thr variant was unable to restore normal basal levels of canonical Wnt/Ī²-catenin signalling in TMEM67-null cells (Abdelhamed et al. 2015. PubMed ID: 26035863). This variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD and has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/1387). Given all the evidence, we interpret c.755T>C (p.Met252Thr) as pathogenic. - |
Nephronophthisis Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at